Revvity (NYSE:RVTY) Releases FY 2026 Earnings Guidance

Revvity (NYSE:RVTY) updated its FY 2026 earnings guidance on Tuesday. The company provided earnings per share guidance of 5.300-5.400 for the period, compared to the consensus estimate of 5.250. The company issued revenue guidance of $2.8 billion-$2.9 billion, compared to the consensus revenue estimate of $2.8 billion.

Revvity Price Performance

RVTY traded down $2.10 during trading on Thursday, hitting $112.92. The company’s stock had a trading volume of 259,219 shares, compared to its average volume of 1,387,167. The company has a current ratio of 1.80, a quick ratio of 1.41 and a debt-to-equity ratio of 0.36. The firm has a market capitalization of $12.60 billion, a price-to-earnings ratio of 53.78, a P/E/G ratio of 2.15 and a beta of 1.07. The business’s fifty day simple moving average is $107.53 and its 200 day simple moving average is $99.91. Revvity has a twelve month low of $81.22 and a twelve month high of $118.30.

Revvity (NYSE:RVTY) last announced its quarterly earnings data on Tuesday, August 4th. The company reported $1.41 earnings per share for the quarter, beating analysts’ consensus estimates of $1.21 by $0.20. The company had revenue of $711.00 million for the quarter, compared to analyst estimates of $702.96 million. Revvity had a return on equity of 8.34% and a net margin of 8.16%.The firm’s revenue for the quarter was down 1.3% on a year-over-year basis. During the same quarter last year, the firm posted $1.18 EPS. Revvity has set its FY 2026 guidance at 5.300-5.400 EPS. On average, equities research analysts forecast that Revvity will post 5.35 EPS for the current fiscal year.

Revvity Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, November 13th. Shareholders of record on Friday, October 23rd will be paid a dividend of $0.07 per share. This represents a $0.28 annualized dividend and a yield of 0.2%. The ex-dividend date of this dividend is Friday, October 23rd. Revvity’s dividend payout ratio (DPR) is 13.40%.

Analyst Upgrades and Downgrades

Several analysts have recently issued reports on RVTY shares. Wall Street Zen cut shares of Revvity from a “buy” rating to a “hold” rating in a research report on Saturday, April 18th. TD Cowen restated a “buy” rating on shares of Revvity in a research report on Wednesday, July 15th. Zacks Research raised Revvity from a “strong sell” rating to a “hold” rating in a research report on Tuesday. Weiss Ratings upgraded shares of Revvity from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Thursday, July 30th. Finally, Evercore restated an “outperform” rating on shares of Revvity in a research note on Wednesday. Three investment analysts have rated the stock with a Buy rating and twelve have assigned a Hold rating to the company’s stock. According to MarketBeat, Revvity currently has an average rating of “Hold” and an average target price of $108.36.

Hedge Funds Weigh In On Revvity

A number of hedge funds have recently made changes to their positions in RVTY. HighTower Advisors LLC raised its holdings in Revvity by 2.6% in the fourth quarter. HighTower Advisors LLC now owns 5,141 shares of the company’s stock worth $497,000 after purchasing an additional 129 shares during the period. Mackenzie Financial Corp grew its stake in Revvity by 1.7% in the third quarter. Mackenzie Financial Corp now owns 8,955 shares of the company’s stock valued at $785,000 after acquiring an additional 154 shares during the period. EverSource Wealth Advisors LLC increased its holdings in shares of Revvity by 25.9% in the second quarter. EverSource Wealth Advisors LLC now owns 900 shares of the company’s stock worth $87,000 after acquiring an additional 185 shares in the last quarter. Schroder Investment Management Group raised its position in shares of Revvity by 5.0% during the third quarter. Schroder Investment Management Group now owns 4,751 shares of the company’s stock worth $416,000 after purchasing an additional 225 shares during the period. Finally, American Century Companies Inc. lifted its holdings in shares of Revvity by 4.3% during the 2nd quarter. American Century Companies Inc. now owns 5,529 shares of the company’s stock valued at $535,000 after purchasing an additional 227 shares in the last quarter. Institutional investors and hedge funds own 86.65% of the company’s stock.

Revvity Company Profile

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.